ACT Medical Secures £1.4M Pre-Seed Funding to Revolutionise First Response Treatment with the Award-Winning REACT System

ACT Medical is proud to announce a groundbreaking milestone in its mission to revolutionize emergency care for victims of violence-related catastrophic hemorrhage, with a special focus on knife crime. The company has successfully raised £1,400,000, marking a remarkable turning point in its journey toward enhanced public safety and innovative medical technology. With this new infusion of capital, ACT Medical will accelerate the development and global deployment of its award-winning REACT system—an international prize-winning method designed to drastically improve the treatment of bleeding within a wound tract. This pioneering approach not only empowers first responders with the tools they need in critical moments, but it also sets a new standard for emergency medical interventions worldwide. The REACT system has already garnered attention from major media outlets, including Sky News, BBC News, The Times, The Independent, ITV News, Channel 4 News, Channel 5 News, Metro, iNews, Dezeen, and The Engineer, highlighting its relevance and potential impact. The fresh funding will be strategically channeled into further refining this state-of-the-art technology, enhancing training programs for emergency personnel, and expanding operational capabilities internationally. By integrating cutting-edge research with practical field application, ACT Medical is taking a vital step towards reducing mortality rates and improving the outcomes of violence-induced injuries. The company’s relentless pursuit of innovation underlines its commitment to safeguarding lives, offering hope and advanced care to communities most in need during emergencies. This funding is not just an investment in technology—it’s an investment in the future of emergency medicine and the protection of human life around the globe.